Advertisement
Journal Home
Search for

Volume 11, Issue 3, Pages 258-262 (March 2010)


View previous. 9 of 25 View next.

Serum nitrite and nitrate levels in children with obstructive sleep-disordered breathing

Athanasios KaditisaCorresponding Author Informationemail address, Emmanouel Alexopoulosa, Georgia Ntamagkaa, Konstantinos Chaidasa, Anastasia Karathanasia, Sofia Gougourab, Afroditi A. Papathanasiouc, Panagiotis Liakosb, Elias Zintzarascd, Konstantinos Gourgoulianisa

Received 3 February 2009; received in revised form 2 March 2009; accepted 14 March 2009.

Abstract 

Background

Diminished nitric oxide (NO) levels have been reported in adults with obstructive sleep apnea but no data are available for children with obstructive sleep-disordered breathing (SDB).

Objectives

To assess levels of serum NO metabolites in children with SDB and to explore the effects of NO metabolites, SDB and their interaction on blood pressure.

Methods

Morning nitrite, the sum of nitrite and nitrate (NOx), and the average of evening and morning blood pressure were assessed in children with SDB referred for polysomnography and in controls without SDB.

Results

Forty-three children with SDB (age: 5.8±2.1years) had moderate-to-severe nocturnal hypoxemia (SpO2 nadir: 85.6±4%), 54 subjects (6.6±2.7years) had mild hypoxemia (SpO2 nadir: 91.4±1.3%) and 20 subjects were controls free of SDB (6.7±3.7years). Subjects with moderate-to-severe hypoxemia had significantly lower ln-transformed NO metabolites (1.4±0.7, nitrites; 2.6±0.5, NOx) compared to those with mild hypoxemia (1.9±0.8, nitrites; 3±0.6, NOx) and controls (2.2±0.7, nitrite; 3±0.6, NOx; p<0.05). The effects of NO metabolites and SDB or their interaction on blood pressure were not significant (p>0.05).

Conclusions

Moderate-to-severe hypoxemia accompanying SDB is associated with reduced concentrations of morning serum NO metabolites, but NO levels do not seem to affect blood pressure.

a Sleep Disorders Laboratory, University of Thessaly School of Medicine, Larissa, Greece

b Department of Biochemistry, University of Thessaly School of Medicine, Larissa, Greece

c Department of Biomathematics, University of Thessaly School of Medicine, Larissa, Greece

d Institute of Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA, USA

Corresponding Author InformationCorresponding author. Tel.: +30 6948530256.

PII: S1389-9457(10)00044-4

doi:10.1016/j.sleep.2009.03.013


View previous. 9 of 25 View next.

Advertisement